On August 21, an invention patent of Wanbangde Pharmaceutical was authorized by the State Intellectual Property Office. The patent name is "a pharmaceutical composition of norfloxacin and its preparation method", and the patent number is ZJ201510829464.8.

All along, the company's R&D center has been committed to the research of key process technologies and innovative drugs. By continuously deepening industry-university-research cooperation, establishing an industry-university-research information communication mechanism, and making full use of the resource advantages of medical colleges, scientific research institutions, and large hospitals, we will further promote the safety evaluation, quality control, production technology, clinical research, and preparation technology of drugs. R&D and other aspects are in line with the world.

The patent of the present invention is a norfloxacin pharmaceutical composition and its preparation method successfully developed by Wanbangde Pharmaceutical after several years of research and development, after repeated tests, and overcoming many difficulties. The composition contains an effective amount of norfloxacin and pharmaceutical excipients, and the proportion of the main drug is 50% to 80%; the pelletizing excipients are selected from microcrystalline cellulose, powdered cellulose, low-substituted hypromellose, One or a combination of cornstarch. The invention also provides a preparation method of the norfloxacin pharmaceutical composition, that is, the pill core is prepared by the extrusion spheronization method, and the capsule is filled after film coating. The norfloxacin pharmaceutical composition of the present invention can control the dissolution rate of the oral preparation on the one hand, and improve the stability of the preparation on the other hand. This invention patent is the company's practice of establishing a scientific and technological innovation incentive mechanism to promote technological innovation and technological revolution of the company, which is conducive to maintaining the company's technological leadership and enhancing the company's technological content and core competitiveness.

In recent years, Wanbangde's pharmaceutical technology innovation work has continuously made new breakthroughs. The company has established a provincial-level academician expert workstation, a provincial-level enterprise research institute for cardiovascular and cerebrovascular drugs, a collaborative innovation alliance of ginkgo leaf drop pills, medical research and enterprise, and introduced a new think tank - academician of the Chinese Academy of Engineering Tang Xican and his team, and academician of the Chinese Academy of Engineering Wang Guangji and his team , help the company to carry out the research and development of related drugs, and drive the continuous improvement of the company's overall scientific research level. With the construction of various incentive mechanisms and talent echelon, the company's patent research and development level is moving towards a higher standard step by step.